← Back to Search

Educational Video + Fact Sheet for Breast and Ovarian Cancer Risk Awareness

N/A
Waitlist Available
Led By Alejandra Hurtado de Mendoza, Ph.D
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-identify as a Latina woman
Have a role in the partner community clinic as either a) full-time or part-time employee b) intern c) volunteer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the post implementation focus groups with community clinics adoption over the previous 48 months will be assessed
Awards & highlights

Study Summary

This trial will test whether a culturally targeted video is more effective than a Spanish-language fact sheet in enhancing genetic counseling and testing uptake and psychosocial outcomes in Latina women at risk for hereditary breast and ovarian cancer.

Who is the study for?
This trial is for Latina women who are at least 18 years old, fluent in Spanish, and have not been involved in previous HBOC or GCT studies. They should meet the NCCN criteria for genetic cancer risk assessment due to personal or family history but haven't undergone genetic counseling or testing for hereditary breast and ovarian cancer.Check my eligibility
What is being tested?
The study compares a culturally targeted video about hereditary breast and ovarian cancer (HBOC) with a Spanish-language fact sheet to see which is more effective at encouraging Latinas to get genetic counseling and testing. It also evaluates how well these tools can be implemented in community clinics.See study design
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating. However, learning about one's potential cancer risks could cause emotional or psychological distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I identify as a Latina woman.
Select...
I work or volunteer at the partner community clinic.
Select...
I am fluent in either English or Spanish.
Select...
I am fluent in Spanish.
Select...
I am 18 years old or older.
Select...
I have never had genetic counseling or testing for breast and ovarian cancer risk.
Select...
I am eligible for a genetic cancer risk assessment due to my or my family's history.
Select...
I have never had genetic counseling or testing for breast or ovarian cancer risk.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from the baseline survey to four months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from the baseline survey to four months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uptake of Genetic Counseling
Uptake of Genetic Testing
Secondary outcome measures
Acceptability of the intervention
Anticipatory emotions about genetic cancer risk assessment
Beliefs and Attitudes about genetic cancer risk assessment
+4 more
Other outcome measures
Acceptability of the Referral Screening Tool
Adoption of the Referral Screening Tool
Feasibility of the Referral Screening Tool
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Video ArmExperimental Treatment1 Intervention
Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." Participants in the video arm will be asked to watch an 18-minute video that the research team developed and tested previously about HBOC and genetic services. The video is recorded with Spanish audio and is available with English subtitles.
Group II: Fact Sheet ArmActive Control1 Intervention
Participants in the Fact Sheet arm will receive a Fact sheet about HBOC and genetic services and will be asked to read it in their own time. The Fact Sheet is available in English and Spanish.

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
341 Previous Clinical Trials
126,170 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,603 Previous Clinical Trials
40,912,943 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
690 Previous Clinical Trials
22,884,584 Total Patients Enrolled

Media Library

Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." Clinical Trial Eligibility Overview. Trial Name: NCT05130606 — N/A
Breast and Ovarian Cancer Research Study Groups: Video Arm, Fact Sheet Arm
Breast and Ovarian Cancer Clinical Trial 2023: Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." Highlights & Side Effects. Trial Name: NCT05130606 — N/A
Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." 2023 Treatment Timeline for Medical Study. Trial Name: NCT05130606 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment opportunities for this clinical trial?

"The information found on clinicaltrials.gov reveals that this medical experiment is not actively recruiting any further candidates. The study was first made public on June 1st, 2021 and has had its details most recently updated November 10th of the same year. Although no longer open for enrollment, there are 512 other trials accepting patients at present."

Answered by AI

What is the overarching purpose of this research?

"The primary goal of this four month long clinical trial is to assess the uptake of genetic counseling. Secondary metrics that will be monitored include acceptability (measured on a scale from 1-10), self-efficacy about attending genetic cancer risk assessment (scored between 1 and 7) and knowledge concerning HBOC (assessed with a 9 item questionnaire)."

Answered by AI

Who else is applying?

What state do they live in?
New York
California
Massachusetts
Other
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~129 spots leftby Dec 2025